Cancer HealthCast: New Technologies Lead to Major Breakthroughs in Cancer Detection, Screening at NCI
Two key programs are playing a vital role in detecting and diagnosing cancer as well as reducing the overall burden on patients and their families.
The National Cancer Institute is utilizing a host of new technologies to diagnose and detect cancer thanks to its Innovative Molecular Analysis Technologies (IMAT) and Informatics Technology for Cancer Research (ITCR) programs. These programs are developing methods that are enhancing cancer research, including artificial intelligence.
Dr. Kelly Crotty, program director for NCI’s Center for Strategic Scientific Initiatives, said not only have the programs helped researchers better identify and screen for cancer, but also they’ve been instrumental in driving progress in clinical care. Crotty also shares updates about NCI’s Liquid Biopsy Consortium and discusses the benefits and challenges she’s seeing with AI.
-
Dr. Kelly Crotty Program Director, Center for Strategic Scientific Initiatives NCI
-
Driving Mission Impact with Scalable AI
IT leaders explore AI innovation, development and integration into cloud environments to drive operational excellence.
33m watch -
NCI's Tech-Based Therapy Helps Patients Battle HPV-Linked Respiratory Disease
A new tech-based therapy is helping NCI treat patients who suffer from a respiratory illness associated with HPV.
23m listen -
Opinion: America's Reindustrialization Must Be AI-Driven
The future of American industry built by artificial intelligence drives a need to upskill the workforce and leverage tariffs carefully.
4m read -
Contact with the Enemy Drives Tech Innovation, Army Officials Say
U.S. Army leaders are testing technology on the battlefield to drive innovation as the service pursues its 2030 modernization goals.
5m read
